News

COVID-19 Combination Clinical Study

COVID-19 Combination Clinical Study

Beaumont Health has launched a new clinical study aimed at treating COVID-19 patients with a combination of naltrexone and ketamine. In spite of the challenges associated with the pandemic, Yourway is maintaining operations across our global network.

Back to Index
Media

Upcoming Event

BIO International Convention

June 8-11, 2020
San Diego, CA, USA (Virtual)

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat
Come chat with us!
Hello! How can I help you?